Drug
Intravenous Iron sucrose
Intravenous Iron sucrose is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
1
20%
Ph not_applicable
1
20%
Ph phase_2
1
20%
Ph phase_4
2
40%
Phase Distribution
0
Early Stage
1
Mid Stage
3
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
2(40.0%)
N/ANon-phased studies
1(20.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(3)
Terminated(1)
Other(1)
Detailed Status
Completed3
unknown1
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (20.0%)
Phase 31 (20.0%)
Phase 42 (40.0%)
N/A1 (20.0%)
Trials by Status
completed360%
unknown120%
withdrawn120%
Recent Activity
0 active trials
Showing 5 of 5
completednot_applicable
Comparison of the Mean Change in Hemoglobin With Ferric Carboxymaltose and IV Iron Sucrose in Anemic Antenatal Patients
NCT07115121
completedphase_4
Oral Liposomal Iron Versus Injectable Iron Sucrose for Anemia Treatment in Non-Dialysis Chronic Kidney Disease Patients
NCT06556134
unknownphase_4
Effect of Lactoferrin Versus Intravenous Iron Sucrose in Treatment of Anemia
NCT05921968
completedphase_3
Iron Supplementation for Acute Anemia After Postbariatric Abdominoplasty
NCT01857011
withdrawnphase_2
IV Iron Sucrose vs Oral FeSO4 in Treating IDA in Pediatric IBD
NCT01438372
Clinical Trials (5)
Showing 5 of 5 trials
NCT07115121Not Applicable
Comparison of the Mean Change in Hemoglobin With Ferric Carboxymaltose and IV Iron Sucrose in Anemic Antenatal Patients
NCT06556134Phase 4
Oral Liposomal Iron Versus Injectable Iron Sucrose for Anemia Treatment in Non-Dialysis Chronic Kidney Disease Patients
NCT05921968Phase 4
Effect of Lactoferrin Versus Intravenous Iron Sucrose in Treatment of Anemia
NCT01857011Phase 3
Iron Supplementation for Acute Anemia After Postbariatric Abdominoplasty
NCT01438372Phase 2
IV Iron Sucrose vs Oral FeSO4 in Treating IDA in Pediatric IBD
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5